124 related articles for article (PubMed ID: 35499789)
1. Prognostic Impact of Postoperative Loss of Skeletal Muscle Mass in Patients Aged 70 Years or Older with Esophageal Cancer.
Harada T; Tatematsu N; Ueno J; Koishihara Y; Konishi N; Hijikata N; Ishikawa A; Tsuji T; Fujiwara H; Fujita T
Ann Surg Oncol; 2022 Sep; 29(9):5638-5645. PubMed ID: 35499789
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of the Loss of Skeletal Muscle Mass During Neoadjuvant Chemotherapy on Older Patients with Esophageal Cancer.
Harada T; Tsuji T; Ueno J; Koishihara Y; Konishi N; Hijikata N; Ishikawa A; Kotani D; Kojima T; Fujiwara H; Fujita T
Ann Surg Oncol; 2022 Dec; 29(13):8131-8139. PubMed ID: 35978207
[TBL] [Abstract][Full Text] [Related]
3. Impact of early postoperative factors on changes in skeletal muscle mass after esophagectomy in older patients with esophageal cancer.
Harada T; Tatematsu N; Ueno J; Koishihara Y; Konishi N; Fukushima T; Fujiwara H; Fujita T; Hijikata N; Wada A; Ishikawa A; Tsuji T
Eur Geriatr Med; 2023 Feb; 14(1):203-210. PubMed ID: 36586085
[TBL] [Abstract][Full Text] [Related]
4. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
Takahashi K; Watanabe M; Kozuki R; Toihata T; Okamura A; Imamura Y; Mine S; Ishizuka N
Ann Surg Oncol; 2019 Oct; 26(11):3727-3735. PubMed ID: 31313039
[TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle loss in the postoperative acute phase after esophageal cancer surgery as a new prognostic factor.
Maeda N; Shirakawa Y; Tanabe S; Sakurama K; Noma K; Fujiwara T
World J Surg Oncol; 2020 Jun; 18(1):143. PubMed ID: 32591002
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of skeletal muscle measurement by computed tomography in patients with esophageal cancer: changes in skeletal muscle mass due to neoadjuvant therapy and the effect on the prognosis.
Yamamoto M; Ozawa S; Koyanagi K; Kazuno A; Ninomiya Y; Yatabe K; Higuchi T; Kanamori K; Tajima K
Surg Today; 2023 Jun; 53(6):692-701. PubMed ID: 36763134
[TBL] [Abstract][Full Text] [Related]
8. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
9. The Optimal Definition of Sarcopenia for Predicting Postoperative Pneumonia after Esophagectomy in Patients with Esophageal Cancer.
Nambara M; Miki Y; Tamura T; Yoshii M; Toyokawa T; Tanaka H; Lee S; Muguruma K; Shibata T; Ohira M
World J Surg; 2021 Oct; 45(10):3108-3118. PubMed ID: 34189621
[TBL] [Abstract][Full Text] [Related]
10. Are muscle parameters obtained by computed tomography associated with outcome after esophagectomy for cancer?
Kemper M; Molwitz I; Krause L; Reeh M; Burdelski C; Kluge S; Yamamura J; Izbicki JR; de Heer G
Clin Nutr; 2021 Jun; 40(6):3729-3740. PubMed ID: 34130018
[TBL] [Abstract][Full Text] [Related]
11. Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.
Kamitani N; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Nakade H; Miyao S; Sho M
Surg Today; 2019 Dec; 49(12):1022-1028. PubMed ID: 31309328
[TBL] [Abstract][Full Text] [Related]
12. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
[TBL] [Abstract][Full Text] [Related]
13. Skeletal Muscle Attenuation (Sarcopenia) Predicts Reduced Overall Survival in Patients with Advanced Epithelial Ovarian Cancer Undergoing Primary Debulking Surgery.
Ataseven B; Luengo TG; du Bois A; Waltering KU; Traut A; Heitz F; Alesina PF; Prader S; Meier B; Schneider S; Koch JA; Walz M; Groeben HT; Nina P; Brunkhorst V; Heikaus S; Harter P
Ann Surg Oncol; 2018 Oct; 25(11):3372-3379. PubMed ID: 30069659
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of surgery-induced sarcopenia in the survival of gastric cancer patients: a sex-specific analysis.
Lee JK; Park YS; Lee K; Youn SI; Won Y; Min SH; Ahn SH; Park DJ; Kim HH
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1897-1907. PubMed ID: 34533290
[TBL] [Abstract][Full Text] [Related]
15. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the skeletal muscle index and an inflammation biomarker in patients with breast cancer who underwent postoperative adjuvant radiotherapy.
Hua X; Deng JP; Long ZQ; Zhang WW; Huang X; Wen W; Guo L; He ZY; Lin HX
Curr Probl Cancer; 2020 Apr; 44(2):100513. PubMed ID: 31732239
[TBL] [Abstract][Full Text] [Related]
17. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy.
Tang R; Deng JP; Zhang L; Zhang WW; Sun JY; Chi F; Zhang J; Wu SG; He ZY
BMC Cancer; 2022 Mar; 22(1):234. PubMed ID: 35241010
[TBL] [Abstract][Full Text] [Related]
19. Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.
Kanemura T; Takeoka T; Sugase T; Urakawa S; Masuike Y; Shinno N; Hara H; Kitakaze M; Kubo M; Mukai Y; Sueda T; Hasegawa S; Akita H; Nishimura J; Wada H; Yasui M; Omori T; Miyata H
Ann Surg Oncol; 2024 Feb; 31(2):818-826. PubMed ID: 37989955
[TBL] [Abstract][Full Text] [Related]
20. The impact of skeletal muscle wasting during neoadjuvant chemotherapy on postoperative anastomotic leakage in patients with esophageal cancer.
Fujihata S; Ogawa R; Nakaya S; Hayakawa S; Okubo T; Sagawa H; Tanaka T; Takahashi H; Matsuo Y; Takiguchi S
Esophagus; 2021 Apr; 18(2):258-266. PubMed ID: 32889673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
